Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories.

Ross CA, Reilmann R, Cardoso F, McCusker EA, Testa CM, Stout JC, Leavitt BR, Pei Z, Landwehrmeyer B, Martinez A, Levey J, Srajer T, Bang J, Tabrizi SJ.

Mov Disord Clin Pract. 2019 Aug 23;6(7):541-546. doi: 10.1002/mdc3.12808. eCollection 2019 Sep. No abstract available.

PMID:
31538087
2.

Huntington disease: A quarter century of progress since the gene discovery.

Testa CM, Jankovic J.

J Neurol Sci. 2019 Jan 15;396:52-68. doi: 10.1016/j.jns.2018.09.022. Epub 2018 Sep 27. Review.

PMID:
30419368
3.

The Changing Age of Individuals Seeking Presymptomatic Genetic Testing for Huntington Disease.

Holman MA, Quillin J, York TP, Testa CM, Rosen AR, Norris VW.

J Genet Couns. 2018 Sep;27(5):1157-1166. doi: 10.1007/s10897-018-0233-9. Epub 2018 Feb 20.

PMID:
29460111
4.

Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society.

Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G; Tremor Task Force of the International Parkinson and Movement Disorder Society.

Mov Disord. 2018 Jan;33(1):75-87. doi: 10.1002/mds.27121. Epub 2017 Nov 30. Review.

5.

New symptomatic therapies for Huntington disease.

Deb A, Frank S, Testa CM.

Handb Clin Neurol. 2017;144:199-207. doi: 10.1016/B978-0-12-801893-4.00017-1. Review.

PMID:
28947118
6.

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.

Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM; Huntington Study Group/Alternatives for Reducing Chorea in Huntington Disease Investigators.

JAMA Neurol. 2017 Aug 1;74(8):977-982. doi: 10.1001/jamaneurol.2017.1352. Erratum in: JAMA Neurol. 2018 Jan 1;75(1):133.

7.

Genome-wide association study in essential tremor identifies three new loci.

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA.

Brain. 2016 Dec;139(Pt 12):3163-3169. Epub 2016 Oct 20.

8.

Knowledge gaps and research recommendations for essential tremor.

Hopfner F, Haubenberger D, Galpern WR, Gwinn K, Van't Veer A, White S, Bhatia K, Adler CH, Eidelberg D, Ondo W, Stebbins GT, Tanner CM, Helmich RC, Lenz FA, Sillitoe RV, Vaillancourt D, Vitek JL, Louis ED, Shill HA, Frosch MP, Foroud T, Kuhlenbäumer G, Singleton A, Testa CM, Hallett M, Elble R, Deuschl G.

Parkinsonism Relat Disord. 2016 Dec;33:27-35. doi: 10.1016/j.parkreldis.2016.10.002. Epub 2016 Oct 4. Review.

9.

Clinical and demographic characteristics related to onset site and spread of cervical dystonia.

Norris SA, Jinnah HA, Espay AJ, Klein C, Brüggemann N, Barbano RL, Malaty IA, Rodriguez RL, Vidailhet M, Roze E, Reich SG, Berman BD, LeDoux MS, Richardson SP, Agarwal P, Mari Z, Ondo WG, Shih LC, Fox SH, Berardelli A, Testa CM, Cheng FC, Truong D, Nahab FB, Xie T, Hallett M, Rosen AR, Wright LJ, Perlmutter JS.

Mov Disord. 2016 Dec;31(12):1874-1882. doi: 10.1002/mds.26817. Epub 2016 Oct 18.

10.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.

JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655.

11.

Transducer-based evaluation of tremor.

Haubenberger D, Abbruzzese G, Bain PG, Bajaj N, Benito-León J, Bhatia KP, Deuschl G, Forjaz MJ, Hallett M, Louis ED, Lyons KE, Mestre TA, Raethjen J, Stamelou M, Tan EK, Testa CM, Elble RJ.

Mov Disord. 2016 Sep;31(9):1327-36. doi: 10.1002/mds.26671. Epub 2016 Jun 6. Review.

12.

Proposing a Parkinson's disease-specific tremor scale from the MDS-UPDRS.

Forjaz MJ, Ayala A, Testa CM, Bain PG, Elble R, Haubenberger D, Rodriguez-Blazquez C, Deuschl G, Martinez-Martin P; International Parkinson and Movement Disorder Society Tremor Rating Scale Task Force.

Mov Disord. 2015 Jul;30(8):1139-43. doi: 10.1002/mds.26271. Epub 2015 Jun 11.

13.

Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood.

Chan AW, Jiang J, Chen Y, Li C, Prucha MS, Hu Y, Chi T, Moran S, Rahim T, Li S, Li X, Zola SM, Testa CM, Mao H, Villalba R, Smith Y, Zhang X, Bachevalier J.

PLoS One. 2015 May 12;10(5):e0122335. doi: 10.1371/journal.pone.0122335. eCollection 2015.

14.

A two years longitudinal study of a transgenic Huntington disease monkey.

Chan AW, Xu Y, Jiang J, Rahim T, Zhao D, Kocerha J, Chi T, Moran S, Engelhardt H, Larkin K, Neumann A, Cheng H, Li C, Nelson K, Banta H, Zola SM, Villinger F, Yang J, Testa CM, Mao H, Zhang X, Bachevalier J.

BMC Neurosci. 2014 Mar 3;15:36. doi: 10.1186/1471-2202-15-36.

15.

Key issues in essential tremor genetics research: Where are we now and how can we move forward?

Testa CM.

Tremor Other Hyperkinet Mov (N Y). 2013;3. pii: tre-03-105-1843-1. doi: 10.7916/D8Q23Z0Z. Epub 2013 Jan 22.

16.

Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort.

Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS Jr, Helmers SL, Factor SA, Jones R, Testa CM.

Mov Disord. 2012 Dec;27(14):1797-800. doi: 10.1002/mds.25237. Epub 2012 Nov 2.

PMID:
23124580
17.

Genetic variants of α-synuclein are not associated with essential tremor.

Ross OA, Conneely KN, Wang T, Vilarino-Guell C, Soto-Ortolaza AI, Rajput A, Wszolek ZK, Uitti RJ, Louis ED, Clark LN, Farrer MJ, Testa CM.

Mov Disord. 2011 Dec;26(14):2552-6. doi: 10.1002/mds.23909. Epub 2011 Oct 24.

18.

LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease.

Vilariño-Güell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ.

Neurogenetics. 2010 Oct;11(4):401-8. doi: 10.1007/s10048-010-0241-x. Epub 2010 Apr 6.

19.

Variant in the sequence of the LINGO1 gene confers risk of essential tremor.

Stefansson H, Steinberg S, Petursson H, Gustafsson O, Gudjonsdottir IH, Jonsdottir GA, Palsson ST, Jonsson T, Saemundsdottir J, Bjornsdottir G, Böttcher Y, Thorlacius T, Haubenberger D, Zimprich A, Auff E, Hotzy C, Testa CM, Miyatake LA, Rosen AR, Kristleifsson K, Rye D, Asmus F, Schöls L, Dichgans M, Jakobsson F, Benedikz J, Thorsteinsdottir U, Gulcher J, Kong A, Stefansson K.

Nat Genet. 2009 Mar;41(3):277-9. doi: 10.1038/ng.299. Epub 2009 Feb 1. Erratum in: Nat Genet. 2009 Apr;41(4):504.

20.

Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease.

Sherer TB, Richardson JR, Testa CM, Seo BB, Panov AV, Yagi T, Matsuno-Yagi A, Miller GW, Greenamyre JT.

J Neurochem. 2007 Mar;100(6):1469-79. Epub 2007 Jan 4.

21.

The deepest divergences in land plants inferred from phylogenomic evidence.

Qiu YL, Li L, Wang B, Chen Z, Knoop V, Groth-Malonek M, Dombrovska O, Lee J, Kent L, Rest J, Estabrook GF, Hendry TA, Taylor DW, Testa CM, Ambros M, Crandall-Stotler B, Duff RJ, Stech M, Frey W, Quandt D, Davis CC.

Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15511-6. Epub 2006 Oct 9.

22.

Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.

Testa CM, Sherer TB, Greenamyre JT.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):109-18. Epub 2005 Jan 6.

PMID:
15790535
23.

Testosterone deficiency in a Parkinson's disease clinic: results of a survey.

Okun MS, Crucian GP, Fischer L, Walter BL, Testa CM, Vitek JL, DeLong MR, Hanfelt J, Huang X.

J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):165-6. No abstract available.

24.

Mechanism of toxicity in rotenone models of Parkinson's disease.

Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT.

J Neurosci. 2003 Nov 26;23(34):10756-64.

25.

Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia.

Bradley SR, Standaert DG, Rhodes KJ, Rees HD, Testa CM, Levey AI, Conn PJ.

J Comp Neurol. 1999 Apr 28;407(1):33-46.

PMID:
10213186
26.

Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat.

Kosinski CM, Standaert DG, Testa CM, Penney JB Jr, Young AB.

Neuroscience. 1998 Oct;86(3):783-98.

PMID:
9692717
27.

Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia.

Testa CM, Friberg IK, Weiss SW, Standaert DG.

J Comp Neurol. 1998 Jan 5;390(1):5-19.

PMID:
9456172
28.

Selective metabotropic receptor agonists distinguish non-ionotropic glutamate binding sites.

Testa CM, Hollingsworth ZR, Shinozaki H, Penney JB Jr, Young AB.

Brain Res. 1997 Oct 31;773(1-2):15-27.

PMID:
9409700
29.

Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain.

Wüllner U, Standaert DG, Testa CM, Penney JB, Young AB.

Brain Res. 1997 Sep 12;768(1-2):215-23.

PMID:
9369318
30.

Glutamate receptor genes in Parkinson's disease.

Penney JB, Standaert DG, Testa CM, Landwehrmeyer GB, Young AB.

Adv Neurol. 1996;69:79-86. Review. No abstract available.

PMID:
8615188
31.

Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation.

Standaert DG, Testa CM, Rudolf GD, Hollingsworth ZR.

J Pharmacol Exp Ther. 1996 Jan;276(1):342-52.

PMID:
8558453
32.

NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum.

Landwehrmeyer GB, Standaert DG, Testa CM, Penney JB Jr, Young AB.

J Neurosci. 1995 Jul;15(7 Pt 2):5297-307.

33.

DNA fragmentation and immediate early gene expression in rat striatum following quinolinic acid administration.

Dure LS 4th, Wiess S, Standaert DG, Rudolf G, Testa CM, Young AB.

Exp Neurol. 1995 Jun;133(2):207-14.

PMID:
7649226
34.

Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons.

Testa CM, Standaert DG, Landwehrmeyer GB, Penney JB Jr, Young AB.

J Comp Neurol. 1995 Apr 3;354(2):241-52.

PMID:
7782501
35.

Metabotropic glutamate receptors are differentially regulated during development.

Catania MV, Landwehrmeyer GB, Testa CM, Standaert DG, Penney JB Jr, Young AB.

Neuroscience. 1994 Aug;61(3):481-95.

PMID:
7969925
36.

Glutamate receptor expression in rat striatum: effect of deafferentation.

Wüllner U, Standaert DG, Testa CM, Landwehrmeyer GB, Catania MV, Penney JB Jr, Young AB.

Brain Res. 1994 Jun 6;647(2):209-19.

PMID:
7922497
37.

Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions.

Wüllner U, Testa CM, Catania MV, Young AB, Penney JB Jr.

Brain Res. 1994 May 9;645(1-2):98-102.

PMID:
8062103
38.

Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat.

Testa CM, Standaert DG, Young AB, Penney JB Jr.

J Neurosci. 1994 May;14(5 Pt 2):3005-18.

39.

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

Standaert DG, Testa CM, Young AB, Penney JB Jr.

J Comp Neurol. 1994 May 1;343(1):1-16.

PMID:
8027428
40.

Differential expression of metabotropic glutamate receptors in the hippocampus and entorhinal cortex of the rat.

Fotuhi M, Standaert DG, Testa CM, Penney JB Jr, Young AB.

Brain Res Mol Brain Res. 1994 Feb;21(3-4):283-92.

41.
42.

Alternatively spliced isoforms of the NMDAR1 glutamate receptor subunit: differential expression in the basal ganglia of the rat.

Standaert DG, Testa CM, Penney JB Jr, Young AB.

Neurosci Lett. 1993 Apr 2;152(1-2):161-4.

PMID:
8515871
43.

Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen.

Evans RL, Wall DW, Platsoucas CD, Siegal FP, Fikrig SM, Testa CM, Good RA.

Proc Natl Acad Sci U S A. 1981 Jan;78(1):544-8.

Supplemental Content

Loading ...
Support Center